For: | Jin S, Chang XC, Wen J, Yang J, Ao N, Zhang KY, Suo LN, Du J. Decarboxylated osteocalcin, a possible drug for type 2 diabetes, triggers glucose uptake in MG63 cells. World J Diabetes 2021; 12(7): 1102-1115 [PMID: 34326958 DOI: 10.4239/wjd.v12.i7.1102] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i7/1102.htm |
Number | Citing Articles |
1 |
Shenghao Li, Liyuan Hao, Xiaoyu Hu. Natural products target glycolysis in liver disease. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1242955
|
2 |
Julian Meyer Berger, Gerard Karsenty. Osteocalcin and the physiology of danger. FEBS Letters 2022; 596(5): 665 doi: 10.1002/1873-3468.14259
|
3 |
Kaberi Chatterjee, Anubroto Pal, Dibya Sundar Padhy, Rajdeep Saha, Amrita Chatterjee, Monika Bharadwaj, Biswatrish Sarkar, Papiya Mitra Mazumder, Sugato Banerjee. Vitamin K2 Ameliorates Diabetes-Associated Cognitive Decline by Reducing Oxidative Stress and Neuroinflammation. Journal of Neuroimmune Pharmacology 2024; 19(1) doi: 10.1007/s11481-024-10156-4
|
4 |
Yixuan Li, Zuhua Gu, Jun Wang, Yangang Wang, Xian Chen, Bingzi Dong. The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.938830
|
5 |
Yuanyuan Zhao, Louisa S Chard Dunmall, Zhenguo Cheng, Yaohe Wang, Lingling Si. Natural products targeting glycolysis in cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1036502
|